Kenvue Inc. (KVUE)
NYSE: KVUE · Real-Time Price · USD
19.24
-0.07 (-0.36%)
At close: Jul 31, 2026, 4:00 PM EDT
19.36
+0.12 (0.62%)
Pre-market: Aug 3, 2026, 4:23 AM EDT
Kenvue Revenue
Kenvue had revenue of $3.91B in the quarter ending March 29, 2026, with 4.49% growth. This brings the company's revenue in the last twelve months to $15.29B, down -0.07% year-over-year. In the year 2025, Kenvue had annual revenue of $15.12B, down -2.14%.
Revenue (ttm)
$15.29B
Revenue Growth
-0.07%
P/S Ratio
2.42
Revenue / Employee
$695,091
Employees
22,000
Market Cap
36.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 15.12B | -331.00M | -2.14% |
| Dec 29, 2024 | 15.46B | 11.00M | 0.07% |
| Dec 31, 2023 | 15.44B | 494.00M | 3.30% |
| Jan 1, 2023 | 14.95B | -104.00M | -0.69% |
| Jan 2, 2022 | 15.05B | 587.00M | 4.06% |
| Jan 3, 2021 | 14.47B | 143.00M | 1.00% |
| Dec 31, 2019 | 14.32B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Procter & Gamble Company | 87.03B |
| Unilever | 57.83B |
| Colgate-Palmolive Company | 21.05B |
| Kimberly-Clark | 16.56B |
| The Estée Lauder Companies | 14.83B |
| Newell Brands | 7.25B |
| The Clorox Company | 6.76B |
| Church & Dwight Co. | 6.23B |
KVUE News
- 3 days ago - Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US - Reuters
- 4 days ago - Kenvue raises quarterly dividend 1.2% to 21c per share - TheFly
- 4 days ago - Kenvue Increases Quarterly Cash Dividend - Business Wire
- 9 days ago - Kenvue confirms FDA approves Tylenol with Naproxen OTC combination - TheFly
- 9 days ago - US FDA approves over-the-counter Tylenol combination pill for pain relief - Reuters
- 10 days ago - Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - Business Wire
- 12 days ago - Kenvue price target raised to $19 from $18 at Barclays - TheFly
- 17 days ago - Kenvue price target raised to $20 from $18 at UBS - TheFly